Reported side effects, bother, satisfaction, and adherence in patients taking hydrocodone for non-cancer pain

Journal of Opioid Management

Volumn 9, Issue 2, 2013, Pages 97-109

  Anastassopoulos, Kathryn P ^a   Chow, Wing ^b   Tapia, Crisanta I ^c   Baik, Rebecca ^a   Moskowitz, Bruce ^b   Kim, Myoung S ^b  

^a Covance Market Access Services Inc   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Department of Genetic and Molecular Toxicology   (United States)

Author keywords

Adherence; Bother; Hydrocodone; Opioids; Pain relief; Patient satisfaction; Quality of life; Side effects

Indexed keywords

HYDROCODONE;

ADULT; ANXIETY; ARTICLE; CAUCASIAN; CONSTIPATION; DEPRESSION; DIZZINESS; DROWSINESS; EXPERIENCE; FATIGUE; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NAUSEA; NEUROPATHIC PAIN; PAIN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCRIPTION; PRURITUS; QUALITY OF LIFE; RASH; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; VOMITING;

ADULT; AGED; ANALGESICS, OPIOID; COST OF ILLNESS; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROCODONE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEURALGIA; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES;

EID: 84877846066     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2012.0151     Document Type: Article

References (22)

1. National Center for Health Statistics Health: special feature on death and dying. Hyattsville, MD. 2011. Available at http://www.cdc.gov/nchs/data/hus/ hus10.pdf. Accessed June 9, 2011.
2. Freynhagen R, Baron R: The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009; 13: 185-190.
3. Berger A, Dukes EM, Oster G: Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004; 5(3): 143-149. (Pubitemid 38879392)
4. McCarberg, BH, Nicholson BD, Todd KH, et al.: The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an internet survey. Am J Ther. 2008; 15(4): 312-320.
5. Bell T, Annuziata K, Leslie J: Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009; 5(3): 137-144.
6. Kelly JP, Cook SF, Kaufman DW, et al.: Prevalence and characteristics of opioid use in the US adult population. Pain. 2008; 138: 507-513.
7. Swegle JM, Logemann C: Management of common opioid-induced adverse effects. Ann Fam Physician. 2006; 74(8): 1347-1354. (Pubitemid 44607306)
8. Benyamin R, Trescot AM, Datta S, et al.: Opioid complications and side effects. Pain Physician. 2008; 11: S105-S120. (Pubitemid 351682081)
9. Clinical Study Report Protocol R331333-PAI-3004 (KF5503/34): Randomized, double-blind, active-controlled, parallel-group, multiple-dose trial conducted in subjects with chronic pain from low back pain or osteoarthritis of the hip or knee of ≥3 months duration. Document ID No.: EDMS-PSDB-6898318:2; J&JPRD, 8 November 2007.
10. Ware JE Jr, Kosinski M, Turner-Bowker DM, et al.: User's Manual for the SF-12u2® Health Survey (with a Supplement Documenting Version 1). Lincoln, RI: QualityMetric Incorporated, 2002.
11. Cleeland CS: The Brief Pain Inventory User Guide. Houston, TX: University of Texas MD Anderson Cancer Center, 2009.
12. Lerner D, Amick BC III, Rogers WH, et al.: The Work Limitations Questionnaire. Med Care 2001; 39(1): 72-85.
13. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006; 22(10): 1911-1920. (Pubitemid 44663395)
14. Bouhassira D, Attal N, Fermanian J, et al.: Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004; 108(3): 248-257. (Pubitemid 38353047)
15. Crawford B, Bouhassira D, Wong A, et al.: Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes. 2008; 18(6): 62.
16. Bouhassira D: Scaling and Scoring of the Neuropathic Pain Symptom Inventory (NPSI), Version 1. Lyon, France: Mapi Research Trust, 2008.
17. Pfizer Global Pharmaceuticals: painDETECT - Scoring of Pain Questionnaire. Pfizer Global Pharmaceuticals, 2006.
18. Lerner D, Rogers W, Chang H: Technical Report: Scoring the Short Form of the Work Limitations Questionnaire (WLQ-SF). Tufts Medical Center. January 23, 2009.
19. Ware JE Jr, Kosinski M, Bjorner JB, et al.: User's Manual for the SF-36v2(tm) Health Survey, 2nd ed. Lincoln, RI: QualityMetric, 2007.
20. Anastassopoulos K, Chow W, Ackerman S, et al.: Oxycodone-related side effects: impact on degree of bother, adherence, pain relief, satisfaction, and quality of life. J Opioid Manag. 2011; 7(3): 203-215.
21. U.S. Census Bureau: Home computers and internet use in the United States - table 2, October 2007. Available at http://www.census.gov/hhes/computer/ publications/2009.html. Accessed October 17, 2011.
22. Chronic low back pain: novel therapies that offer improved efficacy compared with current NSAIDs and opioids must also have advantages in safety and tolerability. Decision Resources, LLC, March 2009. Available at http://decisionresources.com/Products-and-Services/Report?r=dbaspd3509. Accessed October 17, 2011.